A randomised phase III study of single fraction radiotherapy compared to multifraction radiotherapy in patients with metastatic spinal cord compression

Radiation therapy uses high-energy x-rays to kill tumor cells. It is not yet known which radiation therapy regimen is more effective in treating metastatic spinal cord compression. This randomised clinical trial is comparing two radiation therapy regimens to see how well they work in treating patients with metastatic spinal cord compression.

Primary Sponsor

University College London (UCL)

Collaborating Groups

Trans Tasman Radiation Oncology Group (TROG)

Final Accrual

694

Trial Chairperson

Dr Tanya Holt

Trial Contact

Kacy.Baumann@health.qld.gov.au

Related Post

10 November, 2026

Golfers tee off for annual TROG fundraiser

LATEST NEWS: 10 November 2026 The Myall Coast Veteran

27 October, 2026

MASTERPLAN trial shows benefit from SBRT in pancreatic cancer

LATEST NEWS: 27 October 2026 Findings from the AGITG/TROG